Hinge Health
+40%
est. 2Y upside i
Rank
#1174
Sector
Digital Health / Healthcare Technology
Est. Liquidity
~0Y
Data Quality
Data: LowHinge Health shows strong fundamentals with a dominant position in digital MSK care, but lack of revenue data in the provided source prevents a precise equity upside calculation.
Last updated: July 3, 2026
Strong growth sustained at 47%+ with margin expansion; IPO momentum drives multiple expansion to 10x forward revenue. Market cap reaches $11.7B.
Growth decays to ~35% in year 2; multiple compresses to 6x forward revenue in line with public comps. Market cap ~$8.5B.
Competitive pressure from Sword Health and big tech, growth slows to <20%; multiple contracts to 3x revenue; market cap falls to $3.9B.
Preference Stack Risk
lowFunding Intensity
2287%As a public company, all preferred converted to common at IPO; no preference overhang remains.
Dilution Risk
lowPublic company with access to public markets; near-term equity raises unlikely given strong cash flow and recent IPO proceeds.
Secondary Liquidity
activeStock is publicly traded on NYSE under ticker HNGE; immediate liquidity for vested shares.
Questions to Ask at the Interview
Strategic questions based on Hinge Health's data — designed to show you've done your homework.
- 1
“How does Hinge Health plan to maintain its competitive moat against well-funded startups like Sword Health and big tech entrants?”
- 2
“With the IPO complete, what are the key growth levers to sustain 40%+ growth in a large but competitive TAM?”
- 3
“Given recent insider stock sales, how should a candidate evaluate the alignment of management incentives with long-term shareholder value?”
Community
Valuation Sentiment
Our model estimates +40% upside. What do you think?
Anonymous. Do not share material non-public information.
Community Discussion
Comments are reviewed before they appear publicly.
Loading comments...
Disclaimer: This analysis is AI-generated and does not constitute financial or career advice. Always conduct your own due diligence.